Biomea Fusion Inc (BMEA)

Jan 06, 2026

Will Biomea Fusion Inc. stock return to pre crisis levels2026 world cup usa national team round of 16 key players build up play expert forecast preview - ulpravda.ru

Jan 06, 2026

Jan 02, 2026

Biomea Fusion looks to major milestones in 2026 - Traders Union

Jan 02, 2026

Dec 31, 2025

Biomea Fusion downgraded to Underweight from Neutral at JPMorgan - MSN

Dec 31, 2025

Dec 29, 2025

Biomea Fusion Inc. (BMEA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 29, 2025

Dec 27, 2025

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 27, 2025

Dec 23, 2025

Biomea Fusion explores challenges of insulin therapy - Traders Union

Dec 23, 2025

Dec 21, 2025

Can Biomea Fusion Inc. stock outperform in 2025 bull marketCEO Change & Detailed Earnings Play Strategies - Улправда

Dec 21, 2025

Dec 20, 2025

Published on: 2025-12-20 18:19:39 - Улправда

Dec 20, 2025

Dec 20, 2025

How interest rate cuts could boost Biomea Fusion Inc. stockWeekly Stock Recap & Daily Momentum Trading Reports - Улправда

Dec 20, 2025

Dec 20, 2025

Published on: 2025-12-20 15:52:57 - Улправда

Dec 20, 2025

Dec 19, 2025

Is Biomea Fusion Inc. stock near bottom after declineJuly 2025 Retail & Weekly Hot Stock Watchlists - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Biomea Fusion Inc. stock split attract more investors2025 Technical Overview & Technical Entry and Exit Alerts - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Published on: 2025-12-19 02:18:12 - Улправда

Dec 18, 2025

Dec 18, 2025

Aug Closing: Will Biomea Fusion Inc. stock outperform growth indexesJuly 2025 Action & Risk Controlled Swing Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

Gap Down: Can Biomea Fusion Inc. stock outperform in 2025 bull market - Улправда

Dec 18, 2025

Dec 18, 2025

Biomea Fusion, Inc.(NasdaqGS: BMEA) dropped from NASDAQ Biotechnology Index - marketscreener.com

Dec 18, 2025

Dec 17, 2025

Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 17, 2025

Dec 16, 2025

Biomea Fusion presents COVALENT-111 study results at WCIRDC - MSN

Dec 16, 2025

Dec 15, 2025

Insider Buying: Biomea Fusion (NASDAQ:BMEA) Insider Acquires 30,000 Shares of Stock - MarketBeat

Dec 15, 2025

Dec 15, 2025

Biomea Fusion Director Rainer M Erdtmann Acquires 30,000 Shares - TradingView — Track All Markets

Dec 15, 2025

Dec 15, 2025

[Form 4] Biomea Fusion, Inc. Insider Trading Activity - Stock Titan

Dec 15, 2025

Dec 12, 2025

JANUS HENDERSON GROUP PLC Acquires Significant Stake in Biomea F - GuruFocus

Dec 12, 2025

Dec 11, 2025

Interim CEO & Director of Biomea Fusion Michael J. Hitchcock Buys 667% More Shares - simplywall.st

Dec 11, 2025

Dec 10, 2025

Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025 - The Manila Times

Dec 10, 2025

Dec 09, 2025

Biomea Fusion Highlights the Future of Menin Inhibitors and Icovamenib in Interview with Dr. Ralph DeFronzo at WCIRDC 2025 - Quiver Quantitative

Dec 09, 2025

Dec 09, 2025

Biomea Fusion (Nasdaq: BMEA) features KOL talk on menin, icovamenib at WCIRDC 2025 - Stock Titan

Dec 09, 2025

Dec 08, 2025

Biomea Fusion : WCIRDC 2025 COVALENT 111 Week 52 final Oral Presentation - marketscreener.com

Dec 08, 2025

Dec 08, 2025

Is Biomea Fusion Inc a good long term investmentEarnings Revision Updates & High Profit Market Growth - earlytimes.in

Dec 08, 2025

Dec 06, 2025

Biomea Fusion reports durable effects of diabetes drug 9 months after dosing - Investing.com Nigeria

Dec 06, 2025

Dec 05, 2025

Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025 - ts2.tech

Dec 05, 2025

Dec 05, 2025

Biomea Fusion Showcases Durable Benefits Of Menin Inhibitor In Type-2 Diabetes - RTTNews

Dec 05, 2025

Dec 05, 2025

Biomea Fusion stock soars after durable diabetes treatment results By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Biomea Fusion stock soars after durable diabetes treatment results - Investing.com

Dec 05, 2025

Dec 05, 2025

Biomea Fusion reports durable effects of diabetes drug 9 months after dosing By Investing.com - Investing.com South Africa

Dec 05, 2025

Dec 05, 2025

Biomea Fusion Presents Promising Results for Icovamenib in Treating Type 2 Diabetes at WCIRDC 2025 - Quiver Quantitative

Dec 05, 2025

Dec 05, 2025

Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) - The Manila Times

Dec 05, 2025

Dec 05, 2025

Is Biomea Fusion Inc. stock a buy before product launchesEarnings Recap Report & Weekly Top Gainers Alerts - Newser

Dec 05, 2025

Dec 04, 2025

BMEA Insider Trading - Quiver Quantitative

Dec 04, 2025

Dec 04, 2025

Biomea Fusion Interim CEO Increases Stake with 100,000 Shares Purchase - TradingView

Dec 04, 2025

Dec 03, 2025

BMEA: Advancing Menin and oral GLP-1 therapies for diabetes, with phase II trials and strong financial runway - TradingView — Track All Markets

Dec 03, 2025

Dec 03, 2025

Biomea Fusion (BMEA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 03, 2025

Dec 02, 2025

Biomea Fusion Director Rainer M Erdtmann Acquires 50,000 Shares - TradingView — Track All Markets

Dec 02, 2025

Dec 02, 2025

Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) - The Manila Times

Dec 02, 2025